Home LiteratureArticle Details
PMID: 344208 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Immunity to Mycobacterium leprae infections induced in mice by BCG vaccination at different times before or after challenge.

Infection and immunity ·Vol. 19 ·No. 2 ·1978-02-00 ·Pages 391-4

Shepard CC, Walker LL, Van Landingham RM

Abstract

Viable suspensions of BCG, an attenuated strain of Mycobacterium bovis, have been previously shown to immunize mice against infections with M. leprae. Usually, the mice have been vaccinated about 1 month before challenge. Experiments have now been carried out with single intradermal injections of BCG given before or after the M. leprae challenge. Approximately equal immunizing effect was seen in one experiment when the BCG was given at -168, -119, -70, and -28 days relative to challenge. Approximately equal protection was observed in another experiment when the vaccine was given at -28, +28, and +56 days. In the latter experiment, however, vaccine given at +91 days appeared to be somewhat less effective. Enlargement of the lymph nodes regional to the intradermal vaccine site persisted for at least the duration of the experiment, approximately 400 days. Thus, antigenic stimulation appears to have continued throughout the period of observation.

MeSH Terms
Animals BCG Vaccine/administration & dosage Immunity Lymph Nodes/microbiology Mice Mycobacterium Infections/immunology,prevention & control Mycobacterium leprae/immunology,isolation & purification Time Factors Vaccination
Chemicals
BCG Vaccine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Shepard C C
Walker L L
Van Landingham R M
References (10)
10 references, click to expand
  1. VACCINATION AGAINST EXPERIMENTAL INFECTION WITH MYCOBACTERIUM LEPRAE.
    Am J Epidemiol. 1965 Mar;81:150-63 PMID: 14261022
  2. Immunity to Mycobacterium leprae infections in mice stimulated by M. leprae, BCG, and graft-versus-host reactions.
    Infect Immun. 1976 Oct;14(4):919-28 PMID: 11189
  3. Lymphocyte migration into cell-mediated immune lesions is inhibited by trypsin.
    Nature. 1977 Jun 9;267(5611):520-2 PMID: 876368
  4. Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
    J Natl Cancer Inst. 1974 Nov;53(5):1325-31 PMID: 4139280
  5. Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
    J Natl Cancer Inst. 1974 Nov;53(5):1313-23 PMID: 4139279
  6. BCG vaccination of children against leprosy. Preliminary findings of the WHO-controlled trial in Burma.
    Bull World Health Organ. 1970;42(2):235-81 PMID: 4246110
  7. A method for counting acid-fast bacteria.
    Int J Lepr Other Mycobact Dis. 1968 Jan-Mar;36(1):78-82 PMID: 4869698
  8. Multiple skin testing in leprosy.
    J Hyg (Lond). 1975 Aug;75(1):57-68 PMID: 807619
  9. Trial of BCG vaccination against leprosy in Uganda.
    Lepr Rev. 1969 Jan;40(1):3-7 PMID: 5778969
  10. Vaccination against human leprosy bacillus infections of mice: protection by BCG given during the incubation period.
    J Immunol. 1966 Feb;96(2):279-83 PMID: 5933642
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1978-02-00
Pages
391-4
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC414095
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com